CD4 and myeloid sarcoma: In line with this concept, human leukocyte antigen (HLA)-DR restricted CD4+ T cells from the majority of MS patients, but not from controls with other neurological diseases, responded to self-IgG from the cerebrospinal fluid (CSF) (15).